Tim Clausen

Tim Clausen (born 12 March 1969) is a structural biologist[1] and a senior scientist at the Research Institute of Molecular Pathology (IMP) in Vienna, Austria.[2]

Tim Clausen
Born
Tim Clausen

(1969-03-12) 12 March 1969
Alma mater
Awards
  • EMBO Young Investigator (2005)
  • EMBO Member (2010)
Scientific career
Fieldsstructural biology, protein folding
Institutions
Thesis (1997)
Doctoral advisorRobert Huber
Websiteclausen.imp.ac.at

Early life and education

Tim Clausen was born in Flensburg, Germany, in 1969. He did his undergraduate studies in biology at the University of Konstanz from 1988. He graduated with a diploma following research at the lab of Sandro Ghisla in 1994. Following his graduation, Clausen joined the lab of Robert Huber at the Max Planck Institute of Biochemistry in Martinsried for his PhD studies. Clausen obtained his PhD in chemistry summa cum laude in 1997.

Career

In 1997, Tim Clausen became a postdoctoral researcher with Albrecht Messerschmidt at the Max Planck Institute of Biochemistry, leading from 1999 on a small group studying pyridoxal phosphate enzymes. He obtained a lecture qualification (Habilitation) in biochemistry by the University of Konstanz in 2001.[3]

In 2002, Tim Clausen became a group leader in structural biology at the Research Institute of Molecular Pathology (IMP) in Vienna. In 2009, he was promoted to senior scientist.[4]

Research

Tim Clausen studies the protein quality control system that cells evolved, and through which molecular chaperones and proteases monitor the functionality of each protein, thereby reducing the amount of misfolded molecules that may undergo dangerous interactions. Tim Clausen and his lab perform structure-function analyses of several eukaryotic and prokaryotic quality control factors to find novel strategies to combat protein-folding diseases and bacterial pathogenicity.[2]

Awards and achievements

Tim Clausen was awarded a Max Planck Fellowship in 1994; the Heinz Mayer-Leibnitz Award of the Deutsche Forschungsgemeinschaft in 2004;[5] he was selected EMBO young investigator in 2005 and elected European Molecular Biology Organization EMBO member in 2010.[6] He was awarded a European Research Council (ERC) advanced grant in 2016.[7]

gollark: No.
gollark: Hmm, slightly less bad perhaps. Which operations are these?
gollark: Doubly linked lists are memory inefficient, slow in operations people actually care about like iteration, and bad for caches.
gollark: .
gollark: If you must *append* fast use a sensible vector with separate capacity and length

References
  1. https://www.dfg.de/download/pdf/gefoerderte_projekte/preistraeger/hml-preis/2003/clausen_lebenslauf.pdf
  2. Pathology, The Research Institute of Molecular. "Tim Clausen - Protein Quality Control - Research Institute of Molecular Pathology (IMP)". The Research Institute of Molecular Pathology.
  3. "Tim - IMP Clausen Group". clausen.imp.ac.at.
  4. Pathology, The Research Institute of Molecular. "Tim Clausen appointed Senior Scientist".
  5. "DFG - Deutsche Forschungsgemeinschaft - Dr. Tim Clausen - Heinz Maier-Leibnitz-Preisträger 2003". www.dfg.de.
  6. "Find people in the EMBO Communities". people.embo.org.
  7. "ERC Funded Projects". 22 February 2017.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.